This alters the function of the proteins promoting cell adhesion and initiating thrombus formation.
It is also vital that the materials used within a hemocompatible coating are non-toxic and the coating itself has a high level of durability. In conjunction with making a device more hemocompatible, a coating cannot cause damage or be toxic to existing cells within the blood or the vessels. It should in fact, as previously discussed, allow cell growth on the surface of the coated device to promote long term hemocompatibility.
The durability performance requirements of the coating is also something that needs to be considered when discussing device longevity. This is because if the coating were to have a low level of durability and came off of the device prior to its intended use, this would then expose its non-hemocompatible surfaces which would increase the risk of clotting cascade and lead to potential device failure and replacement. Any potential risks of thrombus formation further down the line would be detrimental to a patient’s health.
Finally, it is important that a coating can be applied uniformly while also only forming a thin layer typically at sub-micron level. This is to ensure that the coating doesn’t inhibit the intended function of the device, in particular Gas Exchange functionality in a ECMO or CPB system design. Adequate uniform of the coating ensures that the applied material is evenly distributed, and that the device is fully covered to prevent any exposure areas of the original material that the medical device is made of to minimize the risk of adverse reactions.